Roche acquires its German PCR testing partner TIB Molbiol

The pharmaceutical and diagnostic giant Roche has signed a takeover contract with its German partner TIB Molbiol, which specializes in rapid tests for the detection of infectious diseases.

The financial outlines are not disclosed in the press release released on Thursday, but the transaction should be finalized before the end of the current year.

The operation will enrich the Rhine mastodon’s portfolio, in particular with tests to identify variants of Sras-Cov-2. The collaboration between Roche and TIB Molbiol dates back two decades already and has focused in particular on the fields of SARS, anthrax, avian flu, swine flu, Ebola and Zika.

Based in Berlin, TIB Molbiol has branches in Austria, Colombia, Italy, Spain and the United States.



See also  FIFA: final adoption of the five changes per match



Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Social Media

Most Popular

On Key

Related Posts

DER SPIEGEL – App update

Please update your application. We have renewed our DER SPIEGEL app. Unfortunately, older app versions no longer work for technical reasons. Please update your app